High-Purity Semaglutide Intermediate P29 (GLP-1(9-37)): Manufacturer & Supplier for API Synthesis
Discover the critical role of Semaglutide Intermediate P29 (GLP-1(9-37)) in the development of advanced GLP-1RA drugs. As a leading manufacturer and supplier, we provide high-purity, animal-free intermediates essential for pharmaceutical API synthesis. Secure your supply chain with our GMP-compliant product.
Get a Quote & SampleUnlocking the Power of GLP-1 Analogues with Precision Intermediate Synthesis
Semaglutide Intermediate P29 (GLP-1(9-37))
As a trusted manufacturer and supplier of high-quality pharmaceutical intermediates in China, we offer Semaglutide Intermediate P29 (GLP-1(9-37)). This critical component is produced using advanced genetic engineering fermentation under stringent GMP conditions, ensuring exceptional purity and safety for your API synthesis needs. Explore competitive pricing for bulk orders.
- High-Purity Semaglutide Intermediate P29: Essential for the synthesis of Semaglutide API, driving advancements in diabetes and obesity treatments.
- Animal-Free Production: Ensures product safety by eliminating risks of viral or exogenous contamination.
- GMP Compliant Manufacturing: Produced in facilities adhering to Good Manufacturing Practices for reliable pharmaceutical use.
- Customizable Packaging and Supply: Available for commercial scale with flexible packaging options to meet your specific requirements.
Advantages of Partnering with Our Semaglutide Intermediate P29 Supplier
Uncompromising Quality and Purity
Our Semaglutide Intermediate P29 boasts a purity of ≥90.0%, manufactured using advanced purification techniques. This ensures consistent and reliable results when you buy for your API production.
Cost-Effective API Synthesis
By sourcing this key intermediate from us, a dedicated supplier, you gain access to competitive price points, optimizing your overall drug development cost.
Reliable Supply Chain Assurance
We ensure stable commercial-scale supply, providing the security needed for large-scale pharmaceutical manufacturing. Rely on us as your dependable manufacturer.
Core Applications of Semaglutide Intermediate P29
Semaglutide API Synthesis
The primary application is as a crucial precursor in the multi-step synthesis of Semaglutide Active Pharmaceutical Ingredient (API), a vital component in modern therapeutic solutions.
Type 2 Diabetes Treatment Development
Facilitates the production of Semaglutide, a 2nd Generation GLP-1RA drug FDA-approved for improving glycemic control in adults with type 2 diabetes.
Obesity and Overweight Management
Enables the synthesis of Semaglutide formulations approved for treating obesity and overweight conditions, addressing a growing global health concern.
Clinical Research and Development
Supports ongoing research and development into new applications and improved formulations of GLP-1 analogues for various metabolic and chronic diseases.